No Data
Express News | Merck: Agreement obtains exclusive global license for Lixin Pharmaceutical's investigational PD-1/VEGF bispecific antibody LM-299.
Express News | Merck & Co Inc - to Record $588 Million Pre-Tax Charge Upon Closing
Express News | Merck & Co Inc - Lanova to Receive $588 Million Upfront, up to $2.7 Billion in Milestones
Express News | Merck Enters Into Exclusive Global License for Lm-299, an Investigational Anti-Pd-1/Vegf Bispecific Antibody From Lanova Medicines Ltd.
Express News | Merck Snags Chinese Cancer Drug in Deal Worth up to $3.3 Billion - Bloomberg News
Express News | Form 13f report shows that Deutsche Bank increased its shareholding in Apple, Broadcom, Meta Platforms, Tesla, and other stocks in the third quarter. They decreased their shareholding in Nvidia, Google C, Merck Pharmaceuticals, Bank of America, and other